BNP Paribas Financial Markets’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.6M | Buy |
|
|||||
2025
Q1 | $50.1M | Sell |
|
|||||
2024
Q4 | $57.8M | Sell |
|
|||||
2024
Q3 | $80.1M | Buy |
|
|||||
2024
Q2 | $67.2M | Buy |
|
|||||
2024
Q1 | $60.7M | Buy |
|
|||||
2023
Q4 | $51.1M | Buy |
|
|||||
2023
Q3 | $42M | Buy |
|
|||||
2023
Q2 | $39.5M | Sell |
|
|||||
2023
Q1 | $60.8M | Sell |
|
|||||
2022
Q4 | $76M | Buy |
|
|||||
2022
Q3 | $58.9M | Buy |
|
|||||
2022
Q2 | $29.7M | Sell |
|
|||||
2022
Q1 | $35.9M | Buy |
|
|||||
2021
Q4 | $39.5M | Buy |
|
|||||
2021
Q3 | $27.8M | Sell |
|
|||||
2021
Q2 | $49.4M | Buy |
|
|||||
2021
Q1 | $32.2M | Buy |
|
|||||
2020
Q4 | $27.5M | Sell |
|
|||||
2020
Q3 | $49.4M | Sell |
|
|||||
2020
Q2 | $52.2M | Buy |
|
|||||
2020
Q1 | $43.1M | Sell |
|
|||||
2019
Q4 | $44M | Sell |
|
|||||
2019
Q3 | $106M | Buy |
|
|||||
2019
Q2 | $43.7M | Sell |
|
|||||
2019
Q1 | $68.1M | Buy |
|
|||||
2018
Q4 | $56.9M | Sell |
|
|||||
2018
Q3 | $79.8M | Buy |
|
|||||
2018
Q2 | $62.4M | Sell |
|
|||||
2018
Q1 | $97.2M | Buy |
|
|||||
2017
Q4 | $87.1M | Sell |
|
|||||
2017
Q3 | $106M | Buy |
|
|||||
2017
Q2 | $72.8M | Sell |
|
|||||
2017
Q1 | $89.3M | Buy |
|
|||||
2016
Q4 | $53.6M | Buy |
|
|||||
2016
Q3 | $47.7M | Buy |
|
|||||
2016
Q2 | $28.6M | Sell |
|
|||||
2016
Q1 | $70.2M | Buy |
|
|||||
2015
Q4 | $58M | Sell |
|
|||||
2015
Q3 | $79.6M | Buy |
|
|||||
2015
Q2 | $61.5M | Sell |
|
|||||
2015
Q1 | $99.5M | Sell |
|
|||||
2014
Q4 | $100M | Buy |
|
|||||
2014
Q3 | $81.1M | Buy |
|
|||||
2014
Q2 | $45.6M | Sell |
|
|||||
2014
Q1 | $72.9M | Sell |
|
|||||
2013
Q4 | $123M | Buy |
|
|||||
2013
Q3 | $104M | Buy |
|
|||||
2013
Q2 | $40.5M | Buy |
|